REQUEST A DEMO
Total
USD $0.00
Search more companies

Abbott Diagnostics Korea Co.,Ltd. (South Korea)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Abbott Diagnostics Korea Co.,Ltd. Profile Updated: October 27, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Abbott Diagnostics Korea Co.,Ltd. is an enterprise in South Korea, with the main office in Yongin. It operates in the Medicinal and Botanical Manufacturing industry. Abbott Diagnostics Korea Co.,Ltd. was incorporated on February 01, 1999. Abbott Diagnostics Korea Co.,Ltd. currently employs 784 (2023) people. In 2022, the company reported a net sales revenue drop of 6.55%. Its total assets decreased by 13.31% over the same period. The net profit margin of Abbott Diagnostics Korea Co.,Ltd. decreased by 1.68% in 2022.

Headquarters
65, Borahagal-ro Giheung-gu Yongin-si Gyeonggi
Yongin; Gyeonggi;

Contact Details: Purchase the Abbott Diagnostics Korea Co.,Ltd. report to view the information.

Website: http://www.abbott.com/poct

Basic Information
Total Employees:
Purchase the Abbott Diagnostics Korea Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Abbott Diagnostics Korea Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Abbott Diagnostics Korea Co.,Ltd. report to view the information.
Incorporation Date:
February 01, 1999
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
5%
Company Performance
Financial values in the chart are available after Abbott Diagnostics Korea Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-6.55%
Total operating revenue
-6.55%
Operating profit (EBIT)
-15.42%
EBITDA
-5.28%
Net Profit (Loss) for the Period
-21.09%
Total assets
-13.31%
Total equity
7.75%
Operating Profit Margin (ROS)
-0.96%
Net Profit Margin
-1.68%
Return on Equity (ROE)
-2.56%
Debt to Equity Ratio
-0.29%
Quick Ratio
5.29%
Cash Ratio
1.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?